HOME SLEEP STUDY
The Peripheral Arterial Tone (PAT™) signal is a non-invasive measure of the arterial pulsatile volume changes at the fingertip.
It is a proprietary technology used to identify respiratory events. Using specific signal patterns, the algorithm provides two indices used in determining the degree of sleep apnea, Apnea-Hypopnea Index (AHI) and Respiratory Disturbance Index (RDI). The PAT™ Signal is measured from the fingertip by recording finger arterial pulsatile volume changes since the finger has its unique physiology with;
High vascular density
Convenient site for measurement
Tremendous blood flow variability (1-100ccm/100g/sec)
Reflection of sympathetic nervous system activation, such that terminates any apnea episode
WatchPAT Patient Instruction Video
PAT™ for Sleep Apnea Identification
The termination of sleep disordered breathing events is associated with an increase in heart rate, blood pressure, and sympathetic activation. This increase in sympathetic activation results in peripheral vasoconstriction. Peripheral Arterial Tonometry (PAT) measures arterial pulse volume changes in the finger as a result of vasomotion (vasoconstriction and vasodilatation). WatchPAT™ uses PAT™ signal to detect apnea events. The algorithm analyses the PAT™ signal together with the pulse rate and the oximetry, to accurately diagnose the sleep apnea indices.
PAT™ is clinically validated against Polysomnography
Polysomnography (PSG) is considered the “gold standard” for sleep assessment of Obstructive Sleep Apnea (OSA). Numerous validations studies demonstrate a high degree of correlation in RDI, AHI and ODI during simultaneous recording of WatchPAT and PSG with R= 0.879 (RDI)-0.893 (AHI) and 0.942 (ODI).1
How does WatchPAT detect Apnea, Hypopnea, and Respiratory Effort Related Arousal (RERA) events?
WatchPATM utilizes Peripheral Arterial Tone (PAT), a special physiological signal that mirrors changes in the autonomic nervous system (ANS) caused by respiratory disturbances during sleep. The ANS regulates many of our basic functions and it does this without our conscious control. Among its activities are the regulation of blood vessel size and blood pressure, airflow in the lungs, and the heart’s electrical activity and ability to contract. WatchPAT’s automatic algorithm analyzes the PAT signal amplitude along with the heart rate and oxygen saturation to identify and classify breathing problems while you sleep. Using specific signal patterns, the algorithm provides two indices that allow a diagnosis of sleep apnea: • AHI (Apnea/Hypopnea Index), which is an index used to calculate sleep apnea severity based on the total number of complete cessations (apneas) and partial obstructions (hypopneas) of breathing per hour of sleep. • RDI (Respiratory Disturbance Index) is used to assess the severity of sleep apnea by measuring respiratory efforts, or RERAs (Respiratory Effort Related Arousals). A RERA is an arousal from sleep that follows 10 seconds or more of increased respiratory effort but does not meet the criteria for apnea or hypopnea. The snoring sensor enables the clinician to determine if the respiratory events are obstructive and the body position sensor enables the clinician to determine if there is a positional component to the sleep apnea
How does WatchPAT detect rapid eye movement (REM) from the finger?
Rapid eye movement (REM) sleep is associated with considerable attenuation of the PAT signal and physiology coupled with specific variations in the PAT amplitude and rate. Based on this specific variability in the PAT and pulse rate signals, REM sleep stage is differentiated from non-REM sleep. In addition, it is differentiated from the wake state by WatchPAT’s advanced actigraphy algorithms. This is clinically important to prevent under-treatment of apnea if predominantly REM-related.
How does WatchPAT detect sleep architecture?
WatchPAT’s sleep/wake detection is based on data recorded by the built-in actigraph. The propriety software’s automatic actigraph algorithm discriminates between sleep and wake states in normal subjects and those with Obstructive Sleep Apnea (OSA). This algorithm makes WatchPAT superior to all other actigraph devices—most of them fail when used with OSA subjects. WatchPAT’s sleep/wake algorithm has been validated and published in peer-reviewed journals. The results show very good agreement between actigraphy and PSG in determining sleep efficiency, total sleep time, and sleep latency (agreement 86% in normal subjects, 86%-mild OSA, 84%-moderate OSA, 80% severe OSA).